Silvia Brugnatelli

4PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Clinical nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 27, 2021
Peripheral Blood Lymphocyte Percentage May Predict Chemotolerance and Survival in Patients with Advanced Pancreatic Cancer. Association between Adaptive Immunity and Nutritional State.

Roberto Aquilani, Silvia Brugnatelli, Roberto Maestri

|Apr 03, 2021
Cytokine-Induced Memory-Like NK Cells with High Reactivity against Acute Leukemia Blasts and Solid Tumor Cells Suitable for Adoptive Immunotherapy Approaches.

Matteo Tanzi, Michela Consonni, Michela Falco

|Oct 02, 2020
Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial.

Manlio Monti, Paolo Morgagni, Oriana Nanni

|Jun 05, 2020
Providing nutritional care to cancer patients during the COVID-19 pandemic: an Italian perspective.

Federica Lobascio, Riccardo Caccialanza, Teresa Monaco

Pageof 1

Frequent Collaborators

2 joint publications

Paolo Pedrazzoli

1 joint publications

Federica Lobascio

1 joint publications

Riccardo Caccialanza

1 joint publications

Emanuele Cereda